|
1
|
Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein.
|
Antimicrob Agents Chemother
|
2005
|
1.66
|
|
2
|
Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus.
|
Antimicrob Agents Chemother
|
2007
|
1.48
|
|
3
|
Mechanisms of daptomycin resistance in Staphylococcus aureus.
|
Int J Antimicrob Agents
|
2006
|
1.43
|
|
4
|
Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter.
|
Antimicrob Agents Chemother
|
2005
|
1.26
|
|
5
|
Multidrug efflux pump overexpression in Staphylococcus aureus after single and multiple in vitro exposures to biocides and dyes.
|
Microbiology
|
2008
|
1.22
|
|
6
|
Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus.
|
Antimicrob Agents Chemother
|
2003
|
1.21
|
|
7
|
Identification and characterization of a novel efflux-related multidrug resistance phenotype in Staphylococcus aureus.
|
J Antimicrob Chemother
|
2002
|
1.11
|
|
8
|
Structural and biochemical characterization of MepR, a multidrug binding transcription regulator of the Staphylococcus aureus multidrug efflux pump MepA.
|
Nucleic Acids Res
|
2009
|
1.05
|
|
9
|
Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.
|
Int J Antimicrob Agents
|
2011
|
1.01
|
|
10
|
MepR, a repressor of the Staphylococcus aureus MATE family multidrug efflux pump MepA, is a substrate-responsive regulatory protein.
|
Antimicrob Agents Chemother
|
2006
|
1.00
|
|
11
|
Ethidium bromide MIC screening for enhanced efflux pump gene expression or efflux activity in Staphylococcus aureus.
|
Antimicrob Agents Chemother
|
2010
|
0.99
|
|
12
|
Expression of multidrug resistance efflux pump genes in clinical and environmental isolates of Staphylococcus aureus.
|
Int J Antimicrob Agents
|
2012
|
0.98
|
|
13
|
The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
|
Antimicrob Agents Chemother
|
2007
|
0.95
|
|
14
|
Inability of a reserpine-based screen to identify strains overexpressing efflux pump genes in clinical isolates of Staphylococcus aureus.
|
Int J Antimicrob Agents
|
2008
|
0.90
|
|
15
|
Effect of substrate exposure and other growth condition manipulations on norA expression.
|
J Antimicrob Chemother
|
2004
|
0.89
|
|
16
|
Phenylpiperidine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus.
|
Int J Antimicrob Agents
|
2003
|
0.84
|
|
17
|
Structural mechanism of transcription regulation of the Staphylococcus aureus multidrug efflux operon mepRA by the MarR family repressor MepR.
|
Nucleic Acids Res
|
2013
|
0.82
|
|
18
|
A new plant-derived antibacterial is an inhibitor of efflux pumps in Staphylococcus aureus.
|
Int J Antimicrob Agents
|
2013
|
0.80
|
|
19
|
Functional consequences of substitution mutations in MepR, a repressor of the Staphylococcus aureus MepA multidrug efflux pump gene.
|
J Bacteriol
|
2013
|
0.80
|
|
20
|
In silico genetic correlations of multidrug efflux pump gene expression in Staphylococcus aureus.
|
Int J Antimicrob Agents
|
2010
|
0.79
|
|
21
|
Mutagenesis and modeling to predict structural and functional characteristics of the Staphylococcus aureus MepA multidrug efflux pump.
|
J Bacteriol
|
2012
|
0.77
|
|
22
|
The molecular mechanisms of allosteric mutations impairing MepR repressor function in multidrug-resistant strains of Staphylococcus aureus.
|
MBio
|
2013
|
0.76
|